ALT PRESS-RELEASE SEC Filing Analysis

Latest settled — T+5d

ALT ▼ -2.68% at T+5d

NEUTRAL call ✗ call lost -2.68% · α vs SPY -3.89% · entry $2.98 → $2.90

Next anchor: T+20d in 15d

Last close $2.73 (close Jun 8) · -8.39% from $2.98 entry

Entry anchored
May 26, 03:59 PM ET
via Databento tick

T+1d

+3.02%

call +3.02% · α +2.47%

$3.07

settled 13d ago

T+5d

-2.68%

call -2.68% · α -3.89%

$2.90

settled 7d ago

T+20d

—

call — · α —

—

in 15d

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

Altimmune announced management participation in upcoming investor conferences, a routine corporate event with no material financial or clinical data disclosed. The press release provides no new information on pemvidutide's clinical progress, regulatory status, or financial performance.

Actionable Insight

This is a routine conference participation announcement with no new material information. No trading action is warranted based on this filing. Monitor for future clinical data readouts or regulatory updates on pemvidutide.

Key Facts

Altimmune management will participate in upcoming investor conferences.
No clinical data, regulatory updates, or financial results were disclosed.
The press release is a standard corporate announcement with no material information.

Financial Impact

No financial impact disclosed.

Risk Factors

No new information to assess pipeline or financial risks.
Conference participation does not alter the company's clinical or regulatory trajectory.

Market Snapshot

Exchange

Nasdaq

Sector

Pharmaceutical Preparations

Analyst Consensus

80% bullish (15 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3301939

15 reports for ALT

T+1T+5T+20T+60

60% Hit rate 3 of 5 directional calls best @ T+5▲ +9.00%Apr 23, 2026

Filters

Reports for ALT — sortable, filterable
	Type				Now
May 28, 2026 12d ago	Press Release BULLISH ★ 7/10	$3.07 $2.87	▼ −6.51%	▼ −6.47%	$2.73 (−11.07%)
May 27, 2026 13d ago	Press Release NEUTRAL ★ 2/10	$2.98 $2.90	▼ −2.68%	▼ −3.89%	$2.73 (−8.39%)
May 13, 2026 27d ago	8-K NEUTRAL ★ 4/10	$3.02 $2.74	▼ −9.27%	▼ −8.11%	$2.73 (−9.60%)
May 13, 2026 27d ago	Press Release NEUTRAL ★ 5/10	$3.02 $2.74	▼ −9.27%	▼ −8.11%	$2.73 (−9.60%)
May 13, 2026 27d ago	Press Release BULLISH ★ 6/10	$3.02 $2.74	▼ −9.27%	▼ −8.11%	$2.73 (−9.60%)
May 6, 2026 4w ago	Press Release NEUTRAL ★ 2/10	$3.26 $3.08	▼ −5.52%	▼ −6.65%	$2.73 (−16.26%)
Apr 24, 2026 6w ago	8-K NEUTRAL ★ 5/10	$2.80 $3.02	▲ +7.86%	▲ +7.46%	$2.73 (−2.50%)
Apr 24, 2026 6w ago	424B5 NEUTRAL ★ 5/10	$2.85 $2.60	▼ −8.77%	▼ −9.68%	$2.73 (−4.21%)
Apr 23, 2026 6w ago	Press Release BEARISH ★ 7/10	$2.89 $2.63	▲ +9.00%	▲ +10.47%	$2.73 (+5.54%)
Apr 22, 2026 6w ago	424B5 NEUTRAL ★ 5/10	$2.89 $2.63	▼ −9.00%	▼ −10.47%	$2.73 (−5.54%)

US Market Status

Market Closed — Opens in 6h 17m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access